Anthem Biosciences share price listed at a premium after its IPO. The IPO was subscribed 67.4 times. Qualified institutional buyers showed ...

Anthem Biosciences share price: Anthem’s IPO did not include a fresh issue, with all proceeds going to existing shareholders. Prior to the ...

Anthem Biosciences will debut on stock exchanges on Monday, July 21, with grey market signals suggesting a potential 29% listing gain over ...

Anthem Biosciences IPO GMP: The IPO attracted strong interest, receiving bids for 17.66 crore shares against 4.4 crore shares on offer. Non...

Anthem Biosciences IPO allotment date: The allotment for Anthem Biosciences IPO is now complete. Investors can check their status on KFin T...

Anthem Biosciences' IPO witnessed strong investor interest, being oversubscribed 2.08 times on Day 2, driven by NIIs. Brokerages recommend ...

Anthem Biosciences launched its IPO on July 14, featuring an offer for sale of Rs 3,395 crore. The Bengaluru-based CRDMO, with a price band...

Anthem Biosciences, a CRDMO, is set to launch an IPO to raise ₹3,395 crore, diluting the promoter group's stake. While revenue and profit h...

Three IPOs—Anthem Biosciences, Spunweb Nonwoven, and Monika Alcobev—aim to raise over Rs 3,600 crore in the week starting July 14. With str...

Anthem Biosciences is launching its IPO from July 14-16. The price is fixed between Rs 540 to Rs 570. The IPO aims to raise Rs 3,395 crore ...

Anthem Biosciences' Rs 3,395 crore IPO will open on July 14 as a complete Offer for Sale by promoters and investors. The Bengaluru-based CR...

Several Indian companies are delaying their initial public offerings. This is due to weak investor sentiment and global economic uncertaint...

The regulator issued its final observations on the draft papers last week. When a company receives a final observation from Sebi, it's a si...

BlueStone Jewellery, Anthem Biosciences, Aye Finance, and GK Energy have received SEBI's approval for their IPOs. BlueStone aims to raise ₹...

Anthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True Nort...

Anthem Biosciences has filed its DRHP for an IPO. The issue comprises an offer for sale of up to Rs 3,395 crore by promoters and investors....

Anthem Biosciences has selected JM Financial as the lead banker for its IPO, along with Citi and JP Morgan. The company plans to raise Rs 3...